Results
1 -
10 of
163Sharon M. Sagnella, Xiaojuan Gong, Minoo J. Moghaddam, Charlotte E. Conn, Kathleen Kimpton, Lynne J. Waddington, Irena Krodkiewska and Calum J. Drummond.
Nanostructured nanoparticles of self-assembled lipid pro-drugs as a route to improved chemotherapeutic agents, Nanoscale, 2011, 3, 919. Capecitabine-based chemotherapy for metastatic colorectal cancer, Journal of Cancer Research and Clinical Oncology Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine, Cancer Chemotherapy and Pharmacology A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer, Cancer Chemotherapy and Pharmacology Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53, Journal of Experimental & Clinical Cancer Research 5-Fluoro-5?-Deoxyuridine is an Inhibitor of Uridylate Nucleotidase in L1210 Leukemaemia, Purine and Pyrimidine Metabolism in Man V Evidence produced in Japan: tegafur-based preparations for postoperative chemotherapy in breast cancer, Breast Cancer Effectiveness of doxifluridine (5u2032-DFUR)/docetaxel against advanced/recurrent gastric cancer showing resistance to various anticancer drug regimens, Gastric Cancer Combined therapy of polyamine antimetabolites and antitumor drugs for human gastric cancer xenotransplanted into nude mice, The Japanese journal of surgery